Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 291031, 8 pages
http://dx.doi.org/10.1155/2014/291031
Clinical Study

Diagnosis of Latent Tuberculosis in Patients with Systemic Lupus Erythematosus: T.SPOT.TB versus Tuberculin Skin Test

1Department of Internal Medicine, University Hospital Virgen de las Nieves, Avenida de las Fuerzas Armadas No. 2, 18004 Granada, Spain
2Department of Infectious Diseases, University Hospital Virgen de las Nieves, Avenida de las Fuerzas Armadas No. 2, 18004 Granada, Spain
3Department of Clinical Analysis, University Hospital Virgen de las Nieves, Avenida de las Fuerzas Armadas No. 2, 18004 Granada, Spain

Received 7 February 2014; Revised 8 April 2014; Accepted 9 April 2014; Published 28 May 2014

Academic Editor: Juan-Manuel Anaya

Copyright © 2014 Maria Del Mar Arenas Miras et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. George and M. D. Tsokos, “Systemic lupus erythematosus,” The New England Journal of Medicine, vol. 365, pp. 2110–2121, 2011. View at Publisher · View at Google Scholar
  2. R. Cervera, M. A. Khamashta, J. Font et al., “Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients,” Medicine, vol. 82, no. 5, pp. 299–308, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. S. B. Greenberg, “Infections in the immunocompromised rheumatologic patients,” Critical Care Clinics, vol. 18, no. 4, pp. 931–956, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. S. T. Victorio-Navarra, E. E. Dy, C. G. Arroyo, and T. P. Torralba, “Tuberculosis among filipino patients with systemic lupus erythematosus,” Seminars in Arthritis and Rheumatism, vol. 26, no. 3, pp. 628–634, 1996. View at Publisher · View at Google Scholar
  5. J. E. Yun, S. W. Lee, T. H. Kim et al., “The incidence and characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea,” Clinical and Experimental Rheumatology, vol. 20, no. 2, pp. 127–132, 2002. View at Google Scholar · View at Scopus
  6. M. Sayarlioglu, M. Inanc, S. Kamali et al., “Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extra-pulmonary localization,” Lupus, vol. 13, no. 4, pp. 274–278, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. L.-S. Tam, E. K. Li, S.-M. Wong, and C.-C. Szeto, “Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong,” Scandinavian Journal of Rheumatology, vol. 31, no. 5, pp. 296–300, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Zhang, D. X. Wang, and L. Ma, “A clinical study of tuberculosis infection in systemic lupus erythematosus,” Zhonghua Nei Ke Za Zhi, vol. 47, no. 10, pp. 808–810, 2008. View at Google Scholar · View at Scopus
  9. C. L. Hou, Y. C. Tsai, L. C. Chen, and J. L. Huang, “Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared,” Clinical Rheumatology, vol. 27, no. 5, pp. 557–563, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. G. Erdozain, G. Ruiz-Irastorza, M. V. Egurbide, A. Martinez-Berriotxoa, and C. Aguirre, “High risk of tuberculosis in systemic lupus erythematosus?” Lupus, vol. 15, no. 4, pp. 232–235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Vadillo Font, C. Hernández-García, E. Pato et al., “Incidence and characteristics of tuberculosis in patients with autoimmune rheumatic diseases,” Revista Clínica Española, vol. 203, no. 4, pp. 178–182, 2003. View at Publisher · View at Google Scholar
  12. R. G. León, R. G. Rasco, E. C. Palomares, F. J. G. Hernández, M. J. C. Palma, and J. S. Román, “Tuberculosis in a cohort of patients with systemic lupus erythematosus,” Reumatología Clínica, vol. 6, no. 5, pp. 256–261, 2010. View at Publisher · View at Google Scholar
  13. S. S. Jick, E. S. Lieberman, M. U. Rahman, and H. K. Choi, “Glucocorticoid use, other associated factors, and the risk of tuberculosis,” Arthritis Care and Research, vol. 55, no. 1, pp. 19–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J. González-Martín, J. M. García-García, L. Anibarro et al., “Consensus document on the diagnosis, treatment and prevention of tuberculosis,” Archivos de Bronconeumología, vol. 46, no. 5, pp. 255–274, 2010. View at Publisher · View at Google Scholar
  15. R. Diel, D. Goletti, G. Ferrara et al., “Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis,” European Respiratory Journal, vol. 37, no. 1, pp. 88–99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Pai, A. Zwerling, and D. Menzies, “Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update,” Annals of Internal Medicine, vol. 149, no. 3, pp. 177–184, 2008. View at Google Scholar · View at Scopus
  17. N. Yilmaz, S. Z. Aydin, N. Inanc, S. Karakurt, H. Direskeneli, and S. Yavuz, “Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients,” Lupus, vol. 21, no. 5, pp. 491–495, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Takeda, T. Nojima, C. Terao et al., “Interferon-gamma release assay for diagnosing Mycobacterium tuberculosis infections in patients with systemic lupus erythematosus,” Lupus, vol. 20, no. 8, pp. 792–800, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. American Thoracic Society, Centers for Disease Control Prevention Infectious Disease Society of America, “Targeted tuberculin testing and treatment of latent tuberculosis infection,” The American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 3, pp. S221–S247, 2000. View at Publisher · View at Google Scholar
  20. F. Alcaide and M. Santi, “Multidrug-resistant tuberculosis,” Enfermedades Infecciosas y Microbiología Clínica, vol. 26, supplement 13, pp. 54–60, 2008. View at Google Scholar
  21. C. V. Font, C. Hernández-García, E. Pato et al., “Incidence and characteristics of tuberculosis in patients with autoimmune rheumatic diseases,” Revista Clínica Española, vol. 203, no. 4, pp. 178–182, 2003. View at Publisher · View at Google Scholar
  22. E. Rodriguez, S. Villarrubia, O. Diaz et al., “Situación de la tuberculosis en España. Casos de tuberculosis declarados a la Red Nacional de Vigilancia Epidemiológica 2010,” Boletín Epidemiológico Semanal ISCIII, vol. 20, pp. 26–41, 2012. View at Google Scholar
  23. M. Fedor and A. Rubinstein, “Effects of long-term low-dose corticosteroid therapy on humoral immunity,” Annals of Allergy, Asthma and Immunology, vol. 97, no. 1, pp. 113–116, 2006. View at Google Scholar · View at Scopus
  24. K. H. Kim, S. W. Lee, W. T. Chung et al., “Serial Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents,” The Korean Journal of Laboratory Medicine, vol. 31, no. 14, pp. 271–278, 2011. View at Publisher · View at Google Scholar
  25. V. Pascual-Ramos, B. Hernández-Cruz, I. Villalobos, J. Sifuentes-Osornio, and J. Alcocer-Varela, “Purified protein derivative reaction in systemic lupus erythematosus patients. Indirect study of cellular immunity,” Lupus, vol. 11, no. 1, pp. 25–30, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. S. M. Behar, D. S. Shin, A. Maier, J. Coblyn, S. Helfgott, and M. E. Weinblatt, “Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy,” Journal of Rheumatology, vol. 36, no. 3, pp. 546–551, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. B. F. Haynes and A. S. Fauci, “The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes,” Journal of Clinical Investigation, vol. 61, no. 3, pp. 703–707, 1978. View at Google Scholar · View at Scopus
  28. G. Ruiz-Irastorza, N. Olivares, I. Ruiz-Arruza, A. Martinez-Berriotxoa, M. Egurbide, and C. Aguirre, “Predictors of major infections in systemic lupus erythematosus,” Arthritis Research & Therapy, vol. 11, no. 4, article R109, 2009. View at Publisher · View at Google Scholar · View at Scopus